Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development

MA Ojemuyiwa, RA Madan… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Prostate cancer (PCa) is the most frequently diagnosed, non-cutaneous
malignancy in Western countries. Until recently, few therapeutic options were available for …
被引用次数：39 相关文章

Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development

MA Ojemuyiwa, RA Madan… - Expert opinion on …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction Prostate cancer (PCa) is the most frequently diagnosed, non-cutaneous
malignancy in Western countries. Until recently, few therapeutic options were available for …

Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.

MA Ojemuyiwa, RA Madan, WL Dahut - Expert Opinion on Emerging …, 2014 - europepmc.org
INTRODUCTION: Prostate cancer (PCa) is the most frequently diagnosed, non-cutaneous
malignancy in Western countries. Until recently, few therapeutic options were available for …